Inventor · disambiguated record
Tie-Lin Wang
Also filed as: WANG TIE-LIN
26 granted patents·7 pending applications·261 citations·filing 2000–2020
96Inventor score
Files withEXELIXIS INC7LUOXIN PHARMACEUTICAL SHANGHAI CO LTD7AUBERSON YVES3MARTIN RICHARD3BUSCH BRETT B2
Top patents by PatentIndex Score
33 records- 0192US7485634B2Azepinoindole and pyridoindole derivatives as pharmaceutical agentsEXELIXIS INC·Filed 2003·Granted Feb 3, 2009·49 cites·100 claims
- 0291US9624192B2Carbamate/urea derivativesAUBERSON YVES·Filed 2016·Granted Apr 18, 2017·11 cites·20 claims
- 0391US8133992B2Azepinoindole and pyridoindole derivatives as pharmaceutical agentsMARTIN RICHARD·Filed 2009·Granted Mar 13, 2012·19 cites·50 claims
- 0491US7998995B2LXR and FXR modulatorsEXELIXIS PATENT CO LLC·Filed 2007·Granted Aug 16, 2011·32 cites·45 claims
- 0591US6291676B1Water-soluble derivatives of camptothecin/homocamptothecinUNIV KENTUCKY RES FOUND·Filed 2000·Granted Sep 18, 2001·48 cites·2 claims
- 0687US7595311B2Azepinoindole derivatives as pharmaceutical agentsEXELIXIS INC·Filed 2003·Granted Sep 29, 2009·29 cites·63 claims
- 0786US8703805B2Modulators of LXRBUSCH BRETT B·Filed 2006·Granted Apr 22, 2014·11 cites·41 claims
- 0884US7115640B2Heterocyclic modulators of nuclear receptorsX CEPTOR THERAPEUTICS INC·Filed 2003·Granted Oct 3, 2006·15 cites·62 claims
- 0982US9273026B2Carbamate/urea derivativesAUBERSON YVES·Filed 2015·Granted Mar 1, 2016·4 cites·24 claims
- 1082US9000022B2Imidazole based LXR modulatorsEXELIXIS PATENT CO LLC·Filed 2013·Granted Apr 7, 2015·6 cites·15 claims
- 1180US9216182B2Carbamate/urea derivatives containing piperidin and piperazin rings as H3 receptor inhibitorsWANG TIE-LIN·Filed 2012·Granted Dec 22, 2015·10 cites·15 claims
- 1279US8026237B2Pyrrole derivatives as pharmaceutical agentsEXELIXIS INC·Filed 2005·Granted Sep 27, 2011·4 cites·18 claims
- 1378US8569352B2Imidazole based LXR modulatorsBUSCH BRETT B·Filed 2006·Granted Oct 29, 2013·3 cites·31 claims
- 1477US11034653B2Crystal form of estrogen receptor inhibitor and preparation method thereforLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2018·Granted Jun 15, 2021·2 cites·12 claims
- 1577US6696473B2Heterocyclic modulators of nuclear receptorsX CEPTOR THERAPEUTICS INC·Filed 2002·Granted Feb 24, 2004·8 cites·62 claims
- 1676US10519143B2Substituted-indole-compounds as estrogen receptor down-regulatorsLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Granted Dec 31, 2019·3 cites·25 claims
- 1769US8785488B2Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesityBOLLU VENKATAIAH·Filed 2010·Granted Jul 22, 2014·3 cites·14 claims
- 1868US8367667B2Pyrrole derivatives as pharmaceutical agentsEXELIXIS INC·Filed 2011·Granted Feb 5, 2013·1 cites·33 claims
- 1967US8487117B2Atropisomers of (hydroxyalkyl) pyrrole derivativesNUSS JOHN·Filed 2009·Granted Jul 16, 2013·1 cites·19 claims
- 2065US8642640B21-phenylpyrrole derivativesNUSS JOHN·Filed 2009·Granted Feb 4, 2014·1 cites·27 claims
- 2162US12098127B2Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method thereforLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted Sep 24, 2024·0 cites·10 claims
- 2261US8466143B2Azepine derivatives as pharmaceutical agentsMARTIN RICHARD·Filed 2004·Granted Jun 18, 2013·1 cites·43 claims
- 2359US8524704B2Azepinoindole derivatives as pharmaceutical agentsBUSCH BRETT·Filed 2009·Granted Sep 3, 2013·0 cites·24 claims
- 2454US2017275264A1Carbamate/urea derivativesAUBERSON YVES·Filed 2017·Application pending·0 cites
- 2551US8163771B211 β-HSD1 modulatorsMARTIN RICHARD·Filed 2009·Granted Apr 24, 2012·0 cites·40 claims
- 2650US2010160369A1S1P1 Agonists and Methods of Making And UsingEXELIXIS INC·Filed 2009·Application pending·0 cites
- 2749US2020317660A1Quinazolinone Compound and Application ThereofLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2018·Application pending·0 cites
- 2849US2022213060A1Crystal Form of Quinazolinone Compound and Preparation Method ThereforLUOXIN HEALTHCARE SCIENCE AND TECH DEVELOPMENT BEIJING LTD·Filed 2020·Application pending·0 cites
- 2947US10774081B2Indolo substituted piperidine compound as estrogen receptor down-regulatorLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Granted Sep 15, 2020·0 cites·5 claims
- 3044US2009203577A1Azepinoindole Derivatives As Pharmaceutical AgentsEXELIXIS INC·Filed 2006·Application pending·0 cites
- 3142US2011144128A1Heterocyclic Carboxamide Compounds as Steroid Nuclear Receptors LigandsEXELIXIS INC·Filed 2006·Application pending·0 cites
- 3239US11639355B2Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitorsLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted May 2, 2023·0 cites·15 claims
- 3337US2019284192A1Nitrogenous macrocyclic compound, preparation method therefor, pharmaceutical composition and application thereofLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →